Parkinson's Disease Clinical Trials in New York

Showing 161-177 of 177 trials

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

NCT00203034

Study for patients currently using Levodopa/Carbidopa who will be assigned to receive either Rasagiline or Placebo

Teva Branded Pharmaceutical Products R&D, Inc.472 participantsStarted May 2000

Chicago, Illinois, United States • New York, New York, United States • Rochester, New York, United States +1 more locations

COMPLETEDPhase 4< 1 mile

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

NCT00043849

The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia complicated by coexistent parkinsonism, or patients with Parkinson's disease with dementia \[PDD\] who have episodes of agitation or psychosis. The secondary aim is to determine the safety and tolerability, particularly the influence on parkinsonism, of quetiapine when used to treat psychosis and/or agitation in patients with dementia complicated by coexistent parkinsonism.

DementiaParkinson Disease

National Institute on Aging (NIA)60 participantsStarted Jul 2002

Birmingham, Alabama, United States • La Jolla, California, United States • Long Beach, California, United States +18 more locations

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Parkinson's Disease Trials in Other Cities

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort

Timing of Levodopa Treatment in Parkinson's Disease

Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients

Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

SLV308 for Treatment of Patients With Early Parkinson's Disease

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Other Conditions in New York